This inventor holds 1 USPTO granted patent. Top assignee: Meiji Dairies Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Philippe Chabert
Introduction
Philippe Chabert is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and patent.
Latest Patents
Chabert holds a patent for the "Use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases." This patent describes a preventive and therapeutic drug that contains a cyclohexenone long-chain alcohol compound. The compound is represented by a specific formula where each of R, R, and R can be a hydrogen atom or a methyl group, and X represents a C10–C28 alkylene or alkenylene group. The invention demonstrates excellent neurite-extension ability and inhibits disorders caused by mutations in the SOD gene. This makes it a valuable active ingredient for treating conditions such as amyotrophic lateral sclerosis.
Career Highlights
Philippe Chabert is associated with Meiji Dairies Corporation, where he continues to advance his research in neurodegenerative diseases. His work has garnered attention for its potential impact on therapeutic strategies in this critical area of health.
Collaborations
Chabert collaborates with talented individuals such as Gaby Schmitt and Celine Girlanda-Junges. Their combined expertise contributes to the innovative research environment at Meiji Dairies Corporation.
Conclusion
Philippe Chabert's contributions to the field of neurodegenerative disease treatment through his patent highlight his role as an influential inventor. His work not only showcases innovation but also holds promise for future therapeutic advancements.